UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 522

Sortiert nach

Neural circuits of anxiolytic and antidepressant pherine molecules

CNS spectrums, 2022-02, Vol.27 (1), p.66-72

2022

Volltextzugriff (PDF)

The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study

Neuropsychopharmacology (New York, N.Y.), 2021-04, Vol.46 (5), p.1004-1010

2021

Volltextzugriff (PDF)

Managing dissociative symptoms following the use of esketamine nasal spray: a case report

International clinical psychopharmacology, 2021-01, Vol.36 (1), p.54

2021

Volltextzugriff (PDF)

A double-blind, randomized, placebo-controlled study assessing the efficacy and tolerability of desvenlafaxine 10 and 50 mg/day in adult outpatients with major depressive disorder

BMC psychiatry, 2013-03, Vol.13 (1), p.94-94, Article 94

2013

Volltextzugriff (PDF)

Efficacy, safety, and tolerability of nivasorexant in adults with binge‐eating disorder: A randomized, Phase II proof of concept trial

The International journal of eating disorders, 2023-11, Vol.56 (11), p.2120-2130

2023

Volltextzugriff (PDF)

Fear and avoidance of eye contact in social anxiety disorder

Comprehensive psychiatry, 2011-01, Vol.52 (1), p.81-87

2011

Volltextzugriff (PDF)

Vortioxetine versus placebo in major depressive disorder comorbid with social anxiety disorder

Depression and anxiety, 2017-12, Vol.34 (12), p.1164-1172

2017

Volltextzugriff (PDF)

Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial

JAMA psychiatry (Chicago, Ill.), 2013-11, Vol.70 (11), p.1190

2013

Volltextzugriff (PDF)

The evidence-based pharmacotherapy of social anxiety disorder

The International Journal of Neuropsychopharmacology, 2013-02, Vol.16 (1), p.235-249

2013

Volltextzugriff (PDF)

Gender differences in social anxiety disorder: Results from the national epidemiologic sample on alcohol and related conditions

Journal of anxiety disorders, 2012-01, Vol.26 (1), p.12-19

2012

Volltextzugriff (PDF)

Effect of as-needed use of intranasal PH94B on social and performance anxiety in individuals with social anxiety disorder

Depression and anxiety, 2016-12, Vol.33 (12), p.1081-1089

2016

Volltextzugriff (PDF)

Childhood maltreatment and social anxiety disorder: implications for symptom severity and response to pharmacotherapy

Depression and anxiety, 2012-02, Vol.29 (2), p.132-139

2012

Volltextzugriff (PDF)

More reasons to be straightforward: Findings and norms for two scales relevant to social anxiety

Journal of anxiety disorders, 2011-06, Vol.25 (5), p.623-630

2011

Volltextzugriff (PDF)

Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder

The American journal of psychiatry, 2005-01, Vol.162 (1), p.151-161

2005

Volltextzugriff (PDF)

SOCIAL ANXIETY DISORDER IN DSM-5

Depression and anxiety, 2014-06, Vol.31 (6), p.472-479

2014

Volltextzugriff (PDF)

Obsessive compulsive personality disorder as a predictor of exposure and ritual prevention outcome for obsessive compulsive disorder

Behaviour research and therapy, 2011-08, Vol.49 (8), p.453-458

2011

Volltextzugriff (PDF)

Effect of an Acute Intranasal Aerosol Dose of PH94B on Social and Performance Anxiety in Women With Social Anxiety Disorder

The American journal of psychiatry, 2014-06, Vol.171 (6), p.675-682

2014

Volltextzugriff (PDF)

Screening for social anxiety disorder with the self-report version of the Liebowitz Social Anxiety Scale

Depression and anxiety, 2009-01, Vol.26 (1), p.34-38

2009

Volltextzugriff (PDF)

Quality of life and functional impairment in obsessive-compulsive disorder: a comparison of patients with and without comorbidity, patients in remission, and healthy controls

Depression and anxiety, 2009-01, Vol.26 (1), p.39-45

2009

Volltextzugriff (PDF)

The OCI-R: Validation of the subscales in a clinical sample

Journal of anxiety disorders, 2007-01, Vol.21 (3), p.394-406

2007

Volltextzugriff (PDF)

A Randomized, Controlled Trial of Cognitive-Behavioral Therapy for Augmenting Pharmacotherapy in Obsessive-Compulsive Disorder

The American journal of psychiatry, 2008-05, Vol.165 (5), p.621-630

2008

Volltextzugriff (PDF)

Empirical Validation and Psychometric Evaluation of the Brief Fear of Negative Evaluation Scale in Patients With Social Anxiety Disorder

Psychological assessment, 2005-06, Vol.17 (2), p.179-190

2005

Volltextzugriff (PDF)

Response versus remission in obsessive-compulsive disorder

The journal of clinical psychiatry, 2006-02, Vol.67 (2), p.269

2006

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in adult outpatients with major depressive disorder

The journal of clinical psychiatry, 2007-11, Vol.68 (11), p.1663

2007

Volltextzugriff (PDF)

Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder

Current medical research and opinion, 2008-07, Vol.24 (7), p.1877-1890

2008

Volltextzugriff (PDF)

1 – 25 von 522

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(314)
Mit Volltextzugriff
(445)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(522)
Japanisch
(33)

Erscheinungsjahr

n.n

Thema

Humans
(277)
Science & Technology
(261)
Life Sciences & Biomedicine
(257)
Psychiatry
(243)
Female
(212)
Male
(207)
Adult
(202)
Biological And Medical Sciences
(174)
Medical Sciences
(174)
Psychology. Psychoanalysis. Psychiatry
(162)
Middle Aged
(121)
Psychopathology. Psychiatry
(121)
Case Studies
(105)
Psychology
(99)
Social Sciences
(97)
Psychology, Clinical
(76)
Adult And Adolescent Clinical Studies
(75)
Adolescent
(72)
Pharmacology. Drug Treatments
(61)
Psychopharmacology
(60)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neural circuits of anxiolytic and antidepressant pherine molecules

The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study

Managing dissociative symptoms following the use of esketamine nasal spray: a case report

A double-blind, randomized, placebo-controlled study assessing the efficacy and tolerability of desvenlafaxine 10 and 50 mg/day in adult outpatients with major depressive disorder

Efficacy, safety, and tolerability of nivasorexant in adults with binge‐eating disorder: A randomized, Phase II proof of concept trial

Fear and avoidance of eye contact in social anxiety disorder

Vortioxetine versus placebo in major depressive disorder comorbid with social anxiety disorder

Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial

The evidence-based pharmacotherapy of social anxiety disorder

Gender differences in social anxiety disorder: Results from the national epidemiologic sample on alcohol and related conditions

Effect of as-needed use of intranasal PH94B on social and performance anxiety in individuals with social anxiety disorder

Childhood maltreatment and social anxiety disorder: implications for symptom severity and response to pharmacotherapy

More reasons to be straightforward: Findings and norms for two scales relevant to social anxiety

Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder

SOCIAL ANXIETY DISORDER IN DSM-5

Obsessive compulsive personality disorder as a predictor of exposure and ritual prevention outcome for obsessive compulsive disorder

Effect of an Acute Intranasal Aerosol Dose of PH94B on Social and Performance Anxiety in Women With Social Anxiety Disorder

Screening for social anxiety disorder with the self-report version of the Liebowitz Social Anxiety Scale

Quality of life and functional impairment in obsessive-compulsive disorder: a comparison of patients with and without comorbidity, patients in remission, and healthy controls

The OCI-R: Validation of the subscales in a clinical sample

A Randomized, Controlled Trial of Cognitive-Behavioral Therapy for Augmenting Pharmacotherapy in Obsessive-Compulsive Disorder

Empirical Validation and Psychometric Evaluation of the Brief Fear of Negative Evaluation Scale in Patients With Social Anxiety Disorder

Response versus remission in obsessive-compulsive disorder

A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in adult outpatients with major depressive disorder

Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder

Suchergebnisse filtern